NMDA RECEPTOR-MEDIATED GLUTAMATE TOXICITY OF CULTURED CEREBELLAR, CORTICAL AND MESENCEPHALIC NEURONS - NEUROPROTECTIVE PROPERTIES OF AMANTADINE AND MEMANTINE

被引:80
作者
WELLER, M [1 ]
FINIELSMARLIER, F [1 ]
PAUL, SM [1 ]
机构
[1] NATL INST MENTAL HLTH,CLIN NEUROSCI BRANCH,MOLEC PHARMACOL SECT,BLDG 10,ROOM 4N224,BETHESDA,MD 20892
关键词
AMANTADINE; MEMANTINE; GLUTAMATE; N-METHYL-D-AMPHETAMINE NEURON; EXCITOTOXICITY; NEUROTOXICITY;
D O I
10.1016/0006-8993(93)90464-X
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Effects of amantadine and memantine on NMDA receptor-mediated glutamate toxicity were studied in cultured cerebellar, cortical and mesencephalic neurons. Both drugs protected cerebellar and cortical neurons against glutamate toxicity, memantine being consistently more effective than amantadine but less effective than MK-801. Glutamate toxicity of dopaminergic neurons in mesencephalic cultures was only mildly attenuated by memantine but was also only incompletely blocked by MK-801. These findings suggest that adamantanamines act by inhibiting NMDA receptor-mediated excitatory neurotransmission. However, since non-NMDA receptors appear to be principal mediators of glutamate toxicity of dopaminergic mesencephalic neurons, adamantanamines may fail to protect the nigrostriatal neurons which specifically degenerate in Parkinson's disease.
引用
收藏
页码:143 / 148
页数:6
相关论文
共 32 条
[2]   LOCALIZATION OF DOPAMINE CARRIERS BY BTCP, A DOPAMINE UPTAKE INHIBITOR, ON NIGRAL CELLS CULTURED INVITRO [J].
CERRUTI, C ;
DRIAN, MJ ;
KAMENKA, JM ;
PRIVAT, A .
BRAIN RESEARCH, 1991, 555 (01) :51-57
[3]  
CHEN HSV, 1992, J NEUROSCI, V12, P4427
[4]   NEUROPROTECTIVE EFFECT OF MEMANTINE DEMONSTRATED INVIVO AND INVITRO [J].
ELNASR, MS ;
PERUCHE, B ;
ROSSBERG, C ;
MENNEL, HD ;
KRIEGLSTEIN, J .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1990, 185 (01) :19-24
[5]   MEMANTINE IS HIGHLY POTENT IN PROTECTING CORTICAL CULTURES AGAINST EXCITOTOXIC CELL-DEATH EVOKED BY GLUTAMATE AND N-METHYL-D-ASPARTATE [J].
ERDO, SL ;
SCHAFER, M .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1991, 198 (2-3) :215-217
[6]   N-METHYL-D-ASPARTATE ANTAGONISTS IN THE TREATMENT OF PARKINSONS-DISEASE [J].
GREENAMYRE, JT ;
OBRIEN, CF .
ARCHIVES OF NEUROLOGY, 1991, 48 (09) :977-981
[7]   THE AMPA RECEPTOR ANTAGONIST NBQX HAS ANTIPARKINSONIAN EFFECTS IN MONOAMINE-DEPLETED RATS AND MPTP-TREATED MONKEYS [J].
KLOCKGETHER, T ;
TURSKI, L ;
HONORE, T ;
ZHANG, ZM ;
GASH, DM ;
KURLAN, R ;
GREENAMYRE, JT .
ANNALS OF NEUROLOGY, 1991, 30 (05) :717-723
[8]   NMDA ANTAGONISTS POTENTIATE ANTIPARKINSONIAN ACTIONS OF L-DOPA IN MONOAMINE-DEPLETED RATS [J].
KLOCKGETHER, T ;
TURSKI, L .
ANNALS OF NEUROLOGY, 1990, 28 (04) :539-546
[9]   EXCITATORY AMINO-ACIDS AND THE BASAL GANGLIA - IMPLICATIONS FOR THE THERAPY OF PARKINSONS-DISEASE [J].
KLOCKGETHER, T ;
TURSKI, L .
TRENDS IN NEUROSCIENCES, 1989, 12 (08) :285-286
[10]   MEMANTINE DISPLACES [H-3]MK-801 AT THERAPEUTIC CONCENTRATIONS IN POSTMORTEM HUMAN FRONTAL-CORTEX [J].
KORNHUBER, J ;
BORMANN, J ;
RETZ, W ;
HUBERS, M ;
RIEDERER, P .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1989, 166 (03) :589-590